mounjaro/tirzepatide FDA approves new version of diabetes drug Mounjaro to be sold for weight loss 1 helps to increase insulin production and release from the pancreas Mounjaro is second obesity drug

None of them come close to matching the weight loss results of pharmaceutical GLP-1 agonists

Consult your doctor if side effects persist or worsen

[1] [5] If tirzepatide is deemed potentially appropriate, your GP will likely refer you to specialist endocrinology services for expert assessment, as off-label prescribing of expensive medications typically requires specialist initiation and shared care arrangements

Cell 80 , 485500.e7 (2020)

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) What it is: NAION is a sudden, painless loss of vision in one eye due to reduced blood flow to the optic nervean eye stroke that can result in permanent vision loss

Mounjaro may have a coverage pathway for Apple Health members with a documented type 2 diabetes diagnosis, but Zepbound and compounded tirzepatide are generally excluded